Regulation of signal transducer and activator of transcription 1 (STAT1) involves posttranslational modifications such as phosphorylation of Tyr701 and Ser727 as well as arginine methylation. 1,2 STAT1 signaling is negatively regulated by protein tyrosine phosphatases (PTPs), suppressors of cytokine signaling (SOCS), and protein inhibitor of activated STAT1 (PIAS) proteins. 1-3 The family of PIAS proteins consists of 5 members that have been implicated in the regulation of several nuclear proteins. PIAS1 and PIAS3 were identified as interaction partners for STAT1 and STAT3, respectively, and they were found to inhibit the DNA-binding activity of activated STATs. [3] [4] [5] The other members, PIASx␣/ARIP3 (androgen receptor-interacting protein 3), PIASx␤/ Miz1, and PIASy, function as transcriptional coregulators for steroid hormone receptors. [6] [7] [8] Recently, several PIAS proteins have been shown to function as E3-type small ubiquitin-like modifier (SUMO) ligases. 9-12 SUMO-1, -2, and -3 are small modifier proteins that are covalently conjugated to specific lysine residues of target proteins. 13 A number of nuclear proteins, such as transcription factors AR, p53, and c-Jun, become modified by SUMO-1 conjugation, and this reversible posttranslational modification has been implicated in regulation of proteinprotein interactions, protein stability, localization, or activity. 9,13,14 However, it is currently unknown whether STAT factors are modified through sumoylation.
Introduction
Regulation of signal transducer and activator of transcription 1 (STAT1) involves posttranslational modifications such as phosphorylation of Tyr701 and Ser727 as well as arginine methylation. 1,2 STAT1 signaling is negatively regulated by protein tyrosine phosphatases (PTPs), suppressors of cytokine signaling (SOCS), and protein inhibitor of activated STAT1 (PIAS) proteins. [1] [2] [3] The family of PIAS proteins consists of 5 members that have been implicated in the regulation of several nuclear proteins. PIAS1 and PIAS3 were identified as interaction partners for STAT1 and STAT3, respectively, and they were found to inhibit the DNA-binding activity of activated STATs. [3] [4] [5] The other members, PIASx␣/ARIP3 (androgen receptor-interacting protein 3), PIASx␤/ Miz1, and PIASy, function as transcriptional coregulators for steroid hormone receptors. [6] [7] [8] Recently, several PIAS proteins have been shown to function as E3-type small ubiquitin-like modifier (SUMO) ligases. [9] [10] [11] [12] SUMO-1, -2, and -3 are small modifier proteins that are covalently conjugated to specific lysine residues of target proteins. 13 A number of nuclear proteins, such as transcription factors AR, p53, and c-Jun, become modified by SUMO-1 conjugation, and this reversible posttranslational modification has been implicated in regulation of proteinprotein interactions, protein stability, localization, or activity. 9, 13, 14 However, it is currently unknown whether STAT factors are modified through sumoylation.
Study design Reagents
Antibodies used include anti-SUMO-1 (mouse anti-GMP-1) (Zymed, San Francisco, CA); anti-HA (clone 16B12) (Berkeley-Antibody, Richmond, CA); anti-Flag (anti-Flag M2) (Sigma Aldrich, St Louis, MO); anti-STAT1 (N terminus) (Transduction Laboratories, BD Biosciences); anti-STAT3 (Santa Cruz Biotechnology, Santa Cruz, CA) biotinylated antimouse (Dako, Glustrup, Denmark) and streptavidin-biotin horseradish peroxidase conjugate (Amersham Pharmacia Biotech, Buckinghamshire, United Kingdom). Human interferon-␥ (huIFN-␥) was purchased from Immugenex, Los Angeles, CA.
Plasmid constructs
SUMO-1-Flag and SUMO-1-Flag-Flag were a kind gift from Dr H. Yasuda. 15 The SUMO-1, Flag-PIAS1, Flag-PIAS1mut (PIAS1⌬310-407), Flag-PIAS3, Flag-ARIP3 Flag-ARIP3mut (ARIP3⌬347-418) plasmids 4,9 as well as STAT1-WT-HA and GAS-luc reporter construct have been previously described. 16 The STAT1 Lys703Arg mutation was created from STAT1-WT-HA using direct polymerase chain reaction (PCR) mutagenesis with the following primers: 5ЈGGAACTGGATATATCAGGACTGAGTTGATTTCTGTGTCTG-3Ј and 5Ј-CAGACACAGAAATCAACTCAGTCCTGATATATCCAGTTCC-3Ј.
Transfections, luciferase assay, and immunodetection
COS-7 cells were electroporated using a Bio-Rad (Hercules, CA) gene pulser at 260 V and 960 microfarads (F) and lysed in Triton X lysis buffer supplemented with 5 mM N-ethylmaleimide (NEM) (Sigma Aldrich). HeLa cells were transfected using a calcium phosphate method. For luciferase assay, U3A cells were transfected using a calcium phosphate method as described. 16 Immunodetection was performed as described. 16 
In vitro sumoylation reaction
GST-SUMO GG -1, GST-Ubc-9, GST-SAE2, and GST-SAE1 were produced in Escherichia coli BL21-CodonPlus bacteria (Stratagene, La Jolla, CA) and purified with glutatione Sepharose 4B (Amersham Pharmacia Biotech).
Purified proteins were eluted in buffer containing 50 mM HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid) (pH 7.8), 100 mM NaCl, 10 mM MgCl 2 , 10% glycerol, and 20 mM glutathione. The conjugation reaction was carried out as described. 9 
Results and discussion
We have previously analyzed PIAS proteins in regulation of steroid receptor and cytokine receptor-mediated transcription. 6, 17 The SUMO E3 ligase function of PIAS proteins prompted us to examine whether STAT1 is subject to sumoylation. The level of free SUMO-1 in cells is low and apparently rate limiting, because ectopic expression of SUMO-1 increases the level of sumoylation of target proteins. To this end, COS-7 cells were transfected with HA-tagged STAT1 (STAT1-WT-HA) alone or together with SUMO-1, Flag-tagged SUMO-1 (Flag-SUMO-1), or tandem FlagFlag-SUMO-1 ( Figure 1A , lanes 1-4). STAT1 was immunoprecipitated with anti-HA antibody and analyzed by immunoblotting.
Both anti-SUMO-1 and anti-HA antibodies reacted with a major band of about 110 kDa in cells transfected with STAT1-WT-HA and SUMO-1 ( Figure 1A, lanes 1-2) . The molecular mass of the recognized protein agrees with the covalent attachment of one SUMO-1 moiety to STAT1. In cells transfected with STAT1-WT-HA and Flag-SUMO-1 or Flag-Flag-SUMO-1, the mobility of the anti-SUMO-1 and anti-HA detected bands was shifted according to the presence of Flag sequences in the SUMO-1 expression constructs ( Figure 1A, lanes 3-4) . This conclusion was verified by immunoprecipitating the same lysates with anti-Flag antibody, where STAT1 was detected only in cells transfected with Flag-tagged SUMO-1 constructs (data not shown).
SUMO-1 is conjugated to targeted proteins at the ⑀-amino group of lysine residues. 13 The attachment of SUMO-1 to its substrates involves a minimal consensus sequence, ⌿KxE ( Figure 1B) . The consensus SUMO-1 target sequence was identified around Lys110 and Lys703 in STAT1. The C-terminal sumoylation sequence is well conserved across species in STAT1, but it is not present in the transactivation domains of other STATs. To investigate whether Lys703 is a target for sumoylation, we constructed a STAT1 Figure 1A , and STAT1 was immunoprecipitated with anti-STAT1 antibody, and immunoblotting was performed with anti-SUMO-1 or anti-STAT1 antibody. (D) The effect of Lys703Arg mutation on STAT1-mediated gene activation in response to IFN-␥ stimulation. U3A clones stably expressing STAT1-WT-HA (U3A-WT1 and U3A-WT2) or STAT1-KR-HA (U3A-KR1 and U3A-HA-KR2) were transiently transfected with SUMO-1 (1 g), GAS-luc reporter plasmid (0.5 g), and pCMV-␤Gal. After 24 hours the cells were starved in 0.5% serum and left unstimulated or stimulated with 10 ng/mL human IFN-␥ for 6 hours followed by luciferase measurement. The mean relative luciferase units Ϯ SD from 3 independent experiments are shown. The lower panel shows the STAT1 levels in different clones.
Lys703Arg mutation (STAT1-KR) and performed similar experiments as described above. The STAT1-KR mutant did not show any SUMO-1 conjugation ( Figure 1A, lanes 5-8) . Furthermore, we performed the sumoylation experiments under cell-free conditions ( Figure 1C) . In vitro sumoylation of STAT1-wild type (STAT1-WT) was readily observed, whereas STAT1-KR was not sumoylated. Together, these results indicate that STAT1 is subject to conjugation of a single SUMO-1 molecule at Lys703. Furthermore, ectopic expression of SUMO-1 induced sumoylation of endogenous STAT1 in HeLa cells ( Figure 1D ). While this paper was under review, sumoylation of STAT1 on Lys703 was reported also by Rogers et al. 18 To investigate the regulation of STAT1 sumoylation and the role of PIAS proteins, the experimental conditions were modified by reducing the amount of exogenous SUMO-1. COS-7 cells were transfected with STAT1-WT-HA with or without different Flagtagged PIAS proteins, PIAS1, PIAS3, ARIP3, and really interesting new gene (RING) fingerlike domain-deficient PIAS mutant (PIAS1mut, ARIP3mut) ( Figure 2A ). Cotransfection of different PIAS proteins strongly enhanced STAT1 sumoylation in a RING finger-dependent manner (Figure 2A ). These results suggest functional redundancy of PIAS proteins as SUMO E3 ligases toward STAT1. Previously PIAS1 has been shown to promote sumoylation of several target proteins such as p53, AR, c-Jun. 9, 14, 15 Thus, various PIAS proteins can interact with several proteins and enhance sumoylation, and the specificity of these interactions and SUMO modification may also involve cell type-specific components.
Next we investigated whether sumoylation of STAT1 is regulated through endogenous IFN-␥ receptor. As shown in Figure 2B , STAT1 was not detectably sumoylated in unstimulated COS-7 cells, but IFN-␥ treatment readily induced sumoylation of STAT1 within 30 minutes with a peak at 2 hours. Furthermore, sumoylation of endogenous STAT1 was detected in HeLa cells after pervanadate treatment (Figure 2C ), suggesting that activation of STAT1 serves as a signal for SUMO-1 conjugation.
The effect of sumoylation on STAT1-mediated transcriptional activity was assessed in U3A cell clones that stably express STAT1-WT or STAT1-KR mutant. The clones expressing the STAT1-KR showed enhanced transcriptional response to IFN-␥ stimulation when compared with STAT1-WT clones ( Figure 2D ). Also in transient transfection system STAT1-KR was a more potent transactivator than STAT1-WT, but the difference was smaller (data not shown). These results suggest that sumoylation has a negative regulatory function for STAT1 and bears clear resemblance to the effects of sumoylation in AR, p53, and IRF-1-mediated gene activation. 6, 14, 15, 19 In summary, we show that STAT1 is subject to sumoylation in IFN-␥ signaling through a single Lys703 residue. Interestingly, several proteins involved in modulation of IFN responses, such as interferon regulatory factor 1 (IRF-1) 19 as well as IFN-inducible proteins PML and SP100, 13 are subject to SUMO-1 conjugation. However, posttranslational modifications of STAT1 have been shown to mediate highly specific functions. Phosphorylation of Ser727 in STAT1 regulates only selected gene responses, 20 and ubiquitination of STAT1 is detected only in certain cell types. 21 The functions of PIAS proteins in cytokine and steroid receptormediated transcriptional regulation have been shown to involve both promoter-as well as cell type-specific components. 6 Likewise, SUMO-1 modification also may modulate highly specific and even cell type-restricted functions of STAT1.
